Westlake Chemical Whiffs on Earnings
Westlake Chemical (NYS: WLK) filed its 10-K on Thursday. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Westlake Chemical beat slightly on revenues and whiffed on earnings per share.
Compared to the prior-year quarter, revenue improved, and GAAP earnings per share dropped significantly.
Margins dropped across the board.
Westlake Chemical booked revenue of $859.2 million. The six analysts polled by S&P Capital IQ anticipated net sales of $843.1 million on the same basis. GAAP reported sales were 8.0% higher than the prior-year quarter's $795.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Non-GAAP EPS came in at $0.40. The seven earnings estimates compiled by S&P Capital IQ averaged $0.62 per share on the same basis. GAAP EPS of $0.39 for Q4 were 69% lower than the prior-year quarter's $1.26 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 9%, 1,160 basis points worse than the prior-year quarter. Operating margin was 5.8%, 1,130 basis points worse than the prior-year quarter. Net margin was 3.1%, 750 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $905.5 million. On the bottom line, the average EPS estimate is $1.21.
Next year's average estimate for revenue is $3.79 billion. The average EPS estimate is $4.63.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 84 members rating the stock outperform and 11 members rating it underperform. Among 23 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 21 give Westlake Chemical a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Westlake Chemical is hold, with an average price target of $43.57.
- Add Westlake Chemical to My Watchlist.
At the time this article was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.